(20S)-Protopanaxadiol

Catalog No. :
ACPEDH567
CAS No. :
30636-90-9
Molecular Formula :
C30H52O3
Molecular Weight :
460.74

IUPAC Name:(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol

(20S)-Protopanaxadiol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(20S)-Protopanaxadiol
IUPAC Name(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol
MDL No.MFCD12032048
Molecular FormulaC30H52O3
Molecular Weight460.74
SMILESCC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C
InChI KeyPYXFVCFISTUSOO-HKUCOEKDSA-N
Synonym(20S)-Protopanaxadiol | 30636-90-9 | 20-Epiprotopanaxadiol | Protopanaxadiol | 20(S)-APPD | 20(S)-protopanaxadiol | MR8AEF5T1N | Dammar-24-ene-3,12,20-triol, (3beta,12beta)- | CHEMBL375563 | CHEBI:75950 | dammar-24-ene-3beta,12beta,20-triol | (3S,5R,8R,9R,10R,12R,13R,14R,17S)-
CAS No.30636-90-9
PubChem CID11213350

Synthetic Route by SureRoute

1. ACPEDH567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACABCJ598 route compound structure diagram
    ACABCJ59852193-54-1 In Stock
  6. Then
  7. ACPEDH567 route product structure diagram
    ACPEDH56730636-90-9
Inquiry

2. ACPEDH567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPEDH567 route product structure diagram
    ACPEDH56730636-90-9
Inquiry

Comments (0)